Want to join the conversation?
$CAH expects CapEx in FY16 of $510-540MM primarily for growth projects in its core businesses, information technology projects and integration of the Cordis acquisition. $CAH expects interest expense to increase in FY16 as a result of the additional $1.5Bil of debt issued to fund the Harvard Drug acquisition and pending Cordis acquisition.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?